معرفی
Garry P. Nolan is the Rachford and Carlota A. Harris Professor in the Department of Pathology at Stanford University School of Medicine. He holds multiple affiliations including memberships in Bio-X, Wu Tsai Human Performance Alliance, Maternal & Child Health Research Institute (MCHRI), and Stanford Cancer Institute. Previously, he directed the Stanford NHLBI Proteomics Center (2010-2015) and served on NIH advisory boards including the NHLBI Board of External Experts and NCI-Frederick Advisory Committee.
Dr. Nolan completed his education with a B.S. in Genetics from Cornell University (1983), Ph.D. in Genetics from Stanford University (1989), and postdoctoral fellowship at MIT in David Baltimore's laboratory (1993).
His research focuses on hematopoiesis, cancer biology, immunology, and computational approaches. Key areas include:
- Development of single-cell analysis technologies (CyTOF mass cytometry)
- Multiparameter Ion Beam Imaging (MIBI) for cancer research
- CODEX platform for high-dimensional tissue imaging
- Systems immunology approaches to study immune function, cancer-immune interactions, and pathogen responses
- Computational modeling of signaling networks in leukemia and lymphoma
His recent publications demonstrate strong focus on spatial tissue analysis, immune responses to pathogens/vaccines, and cancer immunotherapy. The work integrates multiplexed imaging, computational modeling, and single-cell technologies to understand tissue organization and immune coordination in health and disease.
Scientific honors include:
- Lifetime Achievement Award (Stanford, 2024)
- Keio University Medical Science Prize (2022)
- Hans Sigrist Prize (2021)
- Nature Publishing Group's Outstanding Research Achievement (2011)
- Teal Innovator Award from DoD (2012-2017)
He currently advises doctoral students including Aaron Tan and postdoctoral fellows Antonio Delgado Gonzalez, Ivan Petrov, and Yuqi Tan. Significant grants include $3.3M DoD Teal Innovator Award for ovarian cancer, $3M FDA grant for immune system reference development, and $3.5M FDA grant for Ebola research platforms.
Dr. Nolan directs the Nolan Lab at Stanford and co-founded multiple biotechnology companies including Rigel, Ionpath, and Akoya. He serves on the Parker Institute for Cancer Immunotherapy and maintains collaborations across statistics, engineering, and computer science departments.
